Clonal Hematopoiesis as a Molecular Risk Factor for Doxorubicin-Induced Cardiotoxicity: A Proof-of-Concept Study.
Jamila MammadovaChristelle M Colin-LeitzingerDiep NguyenRahul MhaskarShridar GanesanYi-Han TangMingxiang TengRoohi Ismail-KhanNancy GillisPublished in: JCO precision oncology (2023)
This study provides preliminary evidence for CH as a predictive risk factor for DIC, which, with further investigation, could serve as an important precision medicine biomarker for the large number of patients with cancer who have CH.